PathWave: Discovering patterns of differentially regulated enzymes in metabolic pathways

Bioinformatics

Volumn 26, Issue 9, 2010, Pages 1225-1231

  Schramm, Gunnar ^a,b   Wiesberg, Stefan ^a   Diessl, Nicolle ^a   Kranz, Anna Lena ^a,b   Sagulenko, Vitalia ^b   Oswald, Marcus ^a   Reinelt, Gerhard ^a   Westermann, Frank ^b   Eils, Roland ^a,b   König, Rainer ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ALGORITHM; ARTICLE; BIOLOGICAL MODEL; BIOLOGY; COMPUTER PROGRAM; COMPUTER SIMULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME; HUMAN; METABOLISM; METHODOLOGY; NEUROBLASTOMA; TUMOR CELL LINE;

ALGORITHMS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; GLUTAMIC ACID; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MODELS, GENETIC; NEUROBLASTOMA; PURINES; PYRIMIDINES; SOFTWARE;

EID: 77952836390     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btq113     Document Type: Article

References (32)

1. Bar-Yehuda, R. et al. (2001) Computing an optimal orientation of a balanced decomposition tree for linear arrangement problems. J. Graph. Alg. Appl., 5, 1-27.
2. Bonferroni, C.E. (1935) Il calcolo delle assicurazioni su gruppi di teste. In, Studi in Onore del Professore Salvatore Ortu Carboni. Rome, 13-60.
3. Chang, T. and Kuo, C.-C. (1993) Texture analysis and classification with tree-structured wavelet transform. IEEE Trans. Image Process., 2, 429-441.
4. Chen, L. and Pankiewicz, K.W. (2007) Recent development of IMP dehydrogenase inhibitors for the treatment of cancer. Curr. Opin. Drug Discov. Dev., 10, 403-412.
5. Christopherson, R.I. et al. (1995) Inhibitors of dihydro-orotase, amidophosphoribosyl transferase and IMP cyclohydrolase as potential drugs. Biochem. Soc. Trans., 23, 888-893.
6. Chuang, H.Y. et al. (2007) Network-based classification of breast cancer metastasis. Mol. Syst. Biol., 3, 140.
7. DeBerardinis, R.J. et al. (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl Acad. Sci. USA, 104, 19345-19350.
8. Dennis, G. Jr. et al. (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol., 4, P3.
9. Fischer, Y. et al. (1997) Glucose transport and glucose transporter GLUT4 are regulated by product(s) of intermediary metabolism in cardiomyocytes. Biochem. J., 321 (Pt 3), 629-638.
10. Gordi, T. and Khamis, H. (2004) Simple solution to a common statistical problem: interpreting multiple tests. Clin. Ther., 26, 780-786.
11. Huang da, W. et al. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protocols, 4, 44-57.
12. Huber, W. et al. (2002) Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics, 18 (Suppl. 1), S96-S104.
13. Jeong, H. et al. (2000) The large-scale organization of metabolic networks. Nature, 407, 651-654.
14. Jones, R.G. and Thompson, C.B. (2009) Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev., 23, 537-548.
15. Kanehisa, M. et al. (2008) KEGG for linking genomes to life and the environment. Nucleic Acids Res., 36, D480-D484.
16. Klimberg, V.S. and McClellan, J.L. (1996) Claude H. Organ, Jr. Honorary Lectureship. Glutamine, cancer, and its therapy. Am. J. Surg., 172, 418-424.
17. König, R. et al. (2006) Discovering functional gene expression patterns in the metabolic network of Escherichia coli with wavelets transforms. BMC Bioinformatics, 7, 119.
18. Mallat, S. (1998) A Wavelet Tour of Signal Processing. Academic Press, New York.
19. Medina, M.A. (2001) Glutamine and cancer. J. Nutrition, 131, 2539S-2542S; discussion 2550S-2531S.
20. Mootha, V.K. et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet., 34, 267-273.
21. Nacu, S. et al. (2007) Gene expression network analysis, and applications to immunology. Bioinformatics, 23, 850-858.
22. Nemhauser, G. and Wolsey, L. (1999) Integer and Combinatorial Optimization. John Wiley & Sons, New York.
23. Oberthuer, A. et al. (2006) Customized oligonucleotide microarray gene expression- based classification of neuroblastoma patients outperforms current clinical risk stratification. J. Clin. Oncol., 24, 5070-5078.
24. Patil, K.R. and Nielsen, J. (2005) Uncovering transcriptional regulation of metabolism by using metabolic network topology. Proc. Natl Acad. Sci. USA, 102, 2685-2689.
25. Rzeski, W. et al. (2002) Glutamate antagonists limit tumor growth. Biochem. Pharmacol., 64, 1195-1200.
26. Schwab, M. et al. (2003) Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol., 4, 472-480.
27. Stankova, J. et al. (2005) Antisense inhibition of methylenetetrahydrofolate reductase reduces cancer cell survival in vitro and tumor growth in vivo. Clin. Cancer Res., 11, 2047-2052.
28. Wang, Q. et al. (2006) Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res., 66, 6050-6062.
29. Westermann, F. et al. (2008) Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas. Genome Biol., 9, R150.
30. Wise, D.R. et al. (2008) Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl Acad. Sci. USA, 105, 18782-18787.
31. Wishart, D.S. et al. (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res., 36, D901-D906.
32. Wishart, D.S. et al. (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res., 34, D668-D672.